The Identification of Metastasis-Related Network Based on a Feature of the Universal Screening of Deficient Mismatch Repair Protein in Colorectal Cancer Patients

2019 ◽  
Author(s):  
Chuan-Wen Fan ◽  
Chao Fang ◽  
Zhao-Ying Lv ◽  
Yuan Li ◽  
Hong Zhang ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Patients ◽  
Mismatch Repair ◽  
Universal Screening ◽  
Repair Protein ◽  
Colorectal Cancer Patients ◽  
Deficient Mismatch Repair ◽  
Mismatch Repair Protein

Mismatch repair protein MSH2 expression and prognosis of colorectal cancer patients

2004 ◽  
Vol 19 (3) ◽  
pp. 190-195
Author(s):  
C.G. Bernardo ◽  
J.J. Gonzalez ◽  
L. Sanz ◽  
E. Barbn ◽  
J.G. Noval ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Patients ◽  
Mismatch Repair ◽  
Repair Protein ◽  
Colorectal Cancer Patients ◽  
Mismatch Repair Protein

Mismatch Repair Protein MSH2 Expression and Prognosis of Colorectal Cancer Patients

2004 ◽  
Vol 19 (3) ◽  
pp. 190-195 ◽  
Author(s):  
C.G. Bernardo ◽  
J.J. Gonzílez ◽  
L. Sanz ◽  
E. Barbón ◽  
J.G. Noval ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Patients ◽  
Vascular Invasion ◽  
Sporadic Colorectal Cancer ◽  
Repair Protein ◽  
N Stage ◽  
Colorectal Cancer Patients ◽  
Mismatch Repair Protein

Introduction and aims The role of genetic factors in the etiology and prognosis of patients with sporadic colorectal cancer is controversial. We have therefore investigated the biological and clinicopathological influence of immunohistochemical MSH2 expression in colorectal cancer. Patients and methods A total of 49 consecutive patients with unselected colorectal cancer operated on in our unit were included in the study. All tumors were resected and tumor specimens were evaluated for MSH2 expression. Clinicopathological data and patient survival were correlated with MSH2 staining. Uni- and multivariate analyses were performed. The minimum follow-up period was five years. Results Curative resection was performed in 34 patients (64.9%), 14 of whom subsequently relapsed. At the end of the overall follow-up 25 (51%) patients had died, 21 of cancer-related causes. Twenty-eight patients (57.1%) were negative for MSH2 staining. Only vascular invasion was significantly correlated with MSH2 expression (lower median values; p=0.04). The overall median survival was 47.9 months (95% CI=27–86.6%). Multivariate analysis of variables in relation to survival showed that T stage (p=0.001), N stage (p<0.001) and MSH2 expression (p=0.01) were independent factors for survival. Conclusions Reduced MSH2 expression is frequent in unselected colorectal cancer patients. Only vascular invasion was correlated with MSH2 expression in this study. Survival was related to TN stage and MSH2 staining.

scholarly journals Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features

2019 ◽  
Vol 144 (9) ◽  
pp. 2161-2168 ◽  
Author(s):  
Wu Jiang ◽  
Mu-Yan Cai ◽  
Shi-Yong Li ◽  
Jin-Xin Bei ◽  
Fang Wang ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Lynch Syndrome ◽  
Cancer Patients ◽  
Universal Screening ◽  
Molecular Features ◽  
High Prevalence ◽  
Colorectal Cancer Patients

Infrequent mismatch repair protein loss in gallbladder cancer patients in Japan

2016 ◽  
Vol 470 (1) ◽  
pp. 109-112
Author(s):  
Hiroshi Yoshida ◽  
Kazuaki Shimada ◽  
Nobuyoshi Hiraoka
Keyword(s):  
Gallbladder Cancer ◽  
Cancer Patients ◽  
Mismatch Repair ◽  
Protein Loss ◽  
Repair Protein ◽  
Mismatch Repair Protein
Sign in / Sign up

Export Citation Format

Share Document